Weight Loss: The average percent weight loss from patients starting weight after these 14 months at the maintenance dose was: -8% weight loss from baseline body weight at 56 weeks at the 3.0mg dose By contrast, the control group saw an average 2.6% weight loss compared to their baseline weight at the 56-week point
Data from 8 randomized controlled trials (6,361 participants) indicated that this level of weight loss could last as long as 3.5 years, although information on long-term safety remains limited
Manufacturing patents are high in volume but lower in commercial impact per patent
Various data types were subjected to a predetermined technique for conversion, resulting in the calculation of their mean and standard deviations (S.D.s) as reported in references [26, 27]
Exercise enhances results but is not required for weight loss It is important to be honest about this: GLP-1 medications produce 1522% body weight loss even without exercise
Midlife women are a particularly important group here